Novartis AG Unloads OTC Products Made at Troubled Nebraska Plant
Staying up-to-date has never been simpler. Sign up for the free
GenePool newsletter today!
As part of its plan to shrink operations at its manufacturing plant in Nebraska, Novartis has sold the US rights to six over-the-counter products, including five that were made at the highly troubled facility. The sale, which was finalized in February, comes as the drugmaker undertakes a strategic review of its over-the-counter product portfolio after a protracted period of weakening sales due to ongoing manufacturing problems. The products that were sold were the Bufferin headache reliever; the Comtrex cough-and-cold reliever; the Doan’s pain reliever; the Myoflex pain relieving cream; the Nupercainal hemorrhoid cream and the Cruex anti-fungal treatment. With the exception of Cruex, all of the products were made at the Lincoln, Nebraska, plant. The drugs were purchased by Duchere Pharma.
Help employers find you! Check out all the jobs and post your resume.
As part of its plan to shrink operations at its manufacturing plant in Nebraska, Novartis has sold the US rights to six over-the-counter products, including five that were made at the highly troubled facility. The sale, which was finalized in February, comes as the drugmaker undertakes a strategic review of its over-the-counter product portfolio after a protracted period of weakening sales due to ongoing manufacturing problems. The products that were sold were the Bufferin headache reliever; the Comtrex cough-and-cold reliever; the Doan’s pain reliever; the Myoflex pain relieving cream; the Nupercainal hemorrhoid cream and the Cruex anti-fungal treatment. With the exception of Cruex, all of the products were made at the Lincoln, Nebraska, plant. The drugs were purchased by Duchere Pharma.
Help employers find you! Check out all the jobs and post your resume.